SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K was filed by Ra Medical Systems, Inc. (not Catheter Precision, Inc.) on February 12, 2021, reporting events as of February 11, 2021. The registrant is a Delaware corporation headquartered in Carlsbad, California, with common stock trading on the NYSE American under the symbol RMED. The company is classified as an emerging growth company.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding corporate governance and shareholder meeting logistics, not a financial performance statement.
Material Changes
The primary material change reported is the rescheduling of the 2021 Annual Meeting of Stockholders. The meeting date has been changed by more than 30 calendar days from the previous year's meeting date.
Guidance, Outlook, and Management Commentary
- 2021 Annual Meeting Date: June 4, 2021.
- Record Date: April 9, 2021 (for determining stockholders entitled to notice and vote).
- Proposal Deadlines: Due to the significant date change, stockholders wishing to submit proposals under Rule 14a-8 or nominate directors under the Bylaws must submit written notice by the close of business on March 1, 2021.
- Submission Address: Ra Medical Systems, Inc., Attention: Corporate Secretary, 2070 Las Palmas Drive, Carlsbad, California 92011.
Key Facts for Investor Verification
- Verify the correct registrant name is Ra Medical Systems, Inc., as the input metadata incorrectly listed "Catheter Precision, Inc."
- Confirm the March 1, 2021 deadline for submitting shareholder proposals or director nominations for the 2021 Annual Meeting.
- Note that the record date for voting eligibility is April 9, 2021.
- Check the company's Bylaws for specific information requirements regarding director nominations and business proposals outside of Rule 14a-8.